I-8 Contrast enhanced magnetic resonance imaging as virtual biopsy for diagnosis and therapeutic assessment of liver malignancies  by Ni, Y.
Bilateral Scientiﬁc & Technological Cooperation Belgium China S3
liver transplants and the 2,043 living related liver
transplantations.
The analysis of the living donor liver transplantations is
done with special focus on recipient selection, type of
indications, outcome and risk of procedure between 1991
and June 2006.
Methods: 54% of European transplant centers have voluntary
participated to the ELTR of living donor transplantation; 34%
of living transplants are done in children and 3% in adults.
Audit visits are performed to assess the quality of the data.
Results: The donors of the living related transplantations
are younger (35±10 years vs 41±18 years, p < 0.01) and
more females have been donors compared to the full-size
transplanted group (50% livings vs 40% full-size). There are
no differences in the age of the adults but the children
transplanted with a living donor are younger. The 8 year
survival of all transplanted grafts from livings is superior
than the one of the full-size grafts (63% vs 54%) mainly
due to the excellent results in children. The results are
equivalent in the adult population with the living donors
as with the full-size whether the indication is cirrosis or
HCC. This is despite the fact that the selection of patients
suffering from HCC could have been more liberal in the
living transplanted group. Living transplantation for HCC
is proportionally also more frequent than in the full-size
group.
When analysing the type of graft used, we ﬁnd that in
91% of adults the right liver was chosen. The majority (85%)
of the children got the left lobe; 12% were transplanted
with left livers and 3% with right livers. The overall survival
was not inﬂuenced by the choice of liver size in children
when differences in survival according to graft volume and
type of grafts where highly signiﬁcant in adults.
The study of the donors shows as expected that the more
liver resected, the more transient hyper bilirubinemia and
liver insufﬁciency but also more biliary complications. Four
donors (0.2%) died; 2 of sepsis and multiple organ failure,
1 of pulmonar embolism and 1 of heart failure.
The main cause of recipient death in the adult transplanted
population is graft failure, related to technical problems
with the vascular anastomosis or insufﬁcient graft volume.
The preventive measures to palliate these problems were
mainly the ligature of the splenic artery and selective
portocaval shunt.
In conclusion: The use of living related liver transplantation
is increasing but still marginal in adult population. The
donor mortality risk is lower than initially estimated but
the donor complication rate remains high. Despite the fact
that HCC is the main indication in adults, the results of the
transplantation are equivalent to those recorded with the
full-size grafts. Technical problems remain frequent mostly
in low volume centers.
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The liver has a unique capacity to regenerate, which allows
it to recover from parenchymal loss or damage without
jeopardizing its vital functions. Amongst the remaining puz-
zles of the complex mechanisms of liver regeneration, what
ﬁrst triggers the regeneration cascade is still debatable.
Shear stress after partial hepatectomy is suggested as a
possible initiator. As the other factors generated by surgical
trauma may also be inﬂuential, we tested this hypothesis
in a novel rat model, in which shear stress was increased
without affecting liver volume and function.
An increase of portal venous pressure, reﬂecting shear
stress, was realised by portal vein arterialisation.
Liver damage was assessed by serum biochemistry and
morphology (light and electron microscopy). Hepatic
proliferating activity was evaluated by proliferating cell
marker Ki-67, mitosis and liver weight. Messenger RNA
expression of endothelial nitric oxide synthase (eNOS) and
immediate early gene c-fos was determined by Q-PCR.
After surgery, portal venous pressure increased to a
level comparable to that of after a standard 2/3 partial
hepatectomy. Despite a transient moderate elevation of
serum aminotransferase, neither parenchymal nor sinusoidal
endothelium damages were identiﬁed by morphology. Forty-
eight hours later, the number of Ki-67+ hepatocytes
was drastically increased, which was accompanied with
numerous mitoses of hepatocytes. Compared with the
control animals, liver weight was also higher in the rats
with high portal pressure. mRNA expression of eNOS and
c-fos was upregulated instantly after portal reperfusion. In
addition, the mRNA expression of both eNOS and c-fos was
correlated to portal pressure.
These data demonstrate that an increased shear stress alone
can initiate hepatic proliferation even without mass loss or
profound injury of the liver. The nitric oxide-c-fos pathway
may be involved in this initiating process.
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Driven by the increasing demands for improved
sensitivity and speciﬁcity in diagnosis of focal hepatic
lesions with magnetic resonance imaging (MRI), a few
hepatobiliary contrast agents (CAs) such as gadolinium
ethoxybenzyl diethylenetriaminopentacetic acid (Gd-EOB-
DTPA, Primovist®), Gadobenate dimeglumine (Gd-BOPTA,
Multihance®), and manganese dipyridoxal-diphosphate (Mn-
DPDP, Teslascan®) have been successfully developed and
applied in clinical patients. Being hepatotropic, these
CAs undergo intracellular uptake and biliary excretion
through certain metabolic pathways, hence well ﬁtting
the current molecular MRI concept. Although they were
originally designed for improving liver lesion detection,
these CAs have been explored during preclinical studies
for noninvasive characterization of histopathological nature
of focal hepatic lesions, i.e. using contrast enhanced
MRI as virtual biopsy. This is realized by exploiting the
difference in uptake and excretion dynamics between
normal liver and neoplastic lesions of different histological
origins and metabolic functions. These CAs were evaluated
by using rodent liver tumor models, and the meticulous
imaging-histology colocalization methodology guaranteed
study reliability. In summary, liver tumors of different origins
and grades of cellular differentiation can be detected and
classiﬁed according to their contrast enhancement patterns
occurring at certain postcontrast phases. The degree or
tendency in invasiveness of liver malignant tumors can be
also implicated by the presence or absence of peritumoral
rim signs. Such diagnostic information, otherwise impossible
or only achievable invasively, may prove invaluable for
decision-making in oncological healthcare. Despite early
objections, our preclinical ﬁndings have been conﬁrmed by
later clinical outcomes when these hepatobiliary CAs are
widely used in human patients.
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